Rocket Doctor AI Reports Growth in Q3 2026

The company saw a surge in patient visits across the United States and Canada throughout the third quarter of 2026.

Updated on Oct. 15, 2026 in Healthcare

Rocket Doctor AI Reports Growth in Q3 2026

Live Poll

Do you believe AI-powered virtual healthcare platforms are improving the quality of patient care?

Rocket Doctor AI completed 53,348 patient visits in the third quarter of 2026, which concluded on September 30. The company anticipates reporting record quarterly revenue following this period of increased operational activity.

Why it matters

The company attributes its rising visit counts to the successful execution of a multi-payer strategy. This approach includes expanding in-network coverage across commercial, Medicare Advantage, and Medicaid health insurance plans in the United States.

Rocket Doctor AI recorded 6,101 U.S. patient visits in Q3 2026, a 56% increase from the prior quarter. Canadian operations saw 47,247 visits, representing a 24% year-over-year growth from Q3 2025.

The players

Rocket Doctor AI

This healthcare technology company is headquartered in Vancouver, BC, and provides virtual medical services.

The details

The firm operates through a multi-payer strategy involving over 20 in-network agreements to facilitate healthcare delivery. Because Rocket Doctor AI recognizes U.S. revenue on a cash basis, there is an inherent lag between the completion of patient visits and the official recognition of revenue.

Timeline

  1. Q3 2025 saw Canadian patient visits total 37,960.

  2. Q2 2026 recorded U.S. patient visits at 3,911.

  3. September 1, 2026, marked the release of news regarding revenue recognition timing.

  4. September 14, 2026, was the date the company issued its latest operational update.

  5. September 30, 2026, concluded the company's third quarter.

Market Landscape

Rocket Doctor AI follows the broader industry trend of consolidating healthcare services through extensive in-network payer agreements. This shift marks a departure from legacy solo-provider telehealth models, emphasizing integration with commercial and public health insurance verticals.

Patients may find increased availability of services as the company moves to convert more out-of-network providers to in-network status. This shift aims to improve insurance coverage for users across Medicaid and Medicare Advantage programs.

The takeaway

The company's reliance on cash-basis revenue recognition in the U.S. creates a reporting delay that investors should consider. Expanding network status remains the primary driver for both patient access and long-term financial scaling.

Further reading

Explore more industry shifts in the Healthcare section.

Live Poll

Do you believe AI-powered virtual healthcare platforms are improving the quality of patient care?